Face Lipoatrophy
-
109.20€Semi-solid calcium hydroxyapatite injectable
INDICATION
The device is indicated for plastic and reconstructive surgery, including deep dermal and sub-dermal soft tissue augmentation of the facial area, and is also intended for restoration and/or correction of the signs of facial fat loss (lipoatrophy) in people with human immunodeficiency virus.
PACKAGING
1 x 1.5 ml
Please read package leaflet before use.
-
43.05€23 mg/ml crosslinked hyaluronic acid injectable
INDICATION
The device is a viscoelastic solution for correcting moderate to severe nasolabial folds.It is used for cosmetic purposes but such device can also address medical reconstructive purposes in the treatment of e.g. facial lipoatrophy, debilitating scars or morphological asymmetry.
PACKAGING
1 x 1 ml
2 x 27G needlesPlease read package leaflet before use.
-
48.00€23 mg/ml crosslinked hyaluronic acid injectable with 0.3% lidocaine
INDICATION
The device indicated for correcting moderate to severe nasolabial folds.It is used for cosmetic purposes but such device can also address medical reconstructive purposes in the treatment of e.g. facial lipoatrophy, debilitating scars or morphological asymmetry.
PACKAGING
1 x 1 ml
2 x 27G needlesPlease read package leaflet before use.
-
47.00€23 mg/ml crosslinked hyaluronic acid injectable
INDICATION
The device is indicated for correcting moderate to severe nasolabial folds.It is used for cosmetic purposes but such device can also address medical reconstructive purposes in the treatment of e.g. facial lipoatrophy, debilitating scars or morphological asymmetry.
PACKAGING
1 x 1 ml
2 x 27G needlesPlease read package leaflet before use.
-
58.00€25 mg/ml crosslinked hyaluronic acid injectable with 0.3% lidocaine
INDICATION
The device is intended for facial tissue augmentation in order to correct midface volume deficit, for restoring facial volume and shaping the contours of the face. The device is conceived for medical purposes and aims to address reconstructive purposes in the treatment, for instance, of HIV-drug related facial lipoatrophy.
PACKAGING
1 x 1 ml
2 x 27G needlesPlease read package leaflet before use.